Loading comparison...
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
No validated longevity dose. Senolytic research uses intermittent 'hit-and-run' D+Q (e.g. dasatinib 100 mg + quercetin for ~2–3 days, repeated periodically) — investigational and only appropriate under medical supervision. Approved leukemia dosing is continuous and higher.
Any time
Oral dasatinib + quercetin (D+Q)
Unknown in humans
Days to weeks (pilot data)
During exposure
Want to compare more supplements?